Additionally, components of sumoylation/desumoylation processes, such as SUMO E2 (ubc9), SUMO E3 (e.g., PIAS1), or SENPs (e.g., SENP1), are upregulated in various cancer types [21–23]. This evidence concerns the gene SENP1 and cancer.